Programmed Death Receptor-1-directed Antibody Interactions [MoA]: Side Effects & Safety Data for 7 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Programmed Death Receptor-1-directed Antibody Interactions [MoA] includes 7 drugs with a combined 212,553 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
7
Drugs in Class
212,553
Combined Reports
All Programmed Death Receptor-1-directed Antibody Interactions [MoA] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| NIVOLUMAB | OPDIVO | 87,742 | 23,086 | 36,530 | 26.3% |
| PEMBROLIZUMAB | KEYTRUDA | 83,779 | 15,543 | 35,472 | 18.6% |
| ATEZOLIZUMAB | Tecentriq Hybreza | 33,703 | 8,520 | 15,094 | 25.3% |
| TISLELIZUMAB | TEVIMBRA | 4,996 | 114 | 2,586 | 2.3% |
| TORIPALIMAB | LOQTORZI | 1,344 | 65 | 823 | 4.8% |
| DOSTARLIMAB | Jemperli | 893 | 130 | 441 | 14.6% |
| RETIFANLIMAB | ZYNYZ | 96 | 17 | 89 | 17.7% |
Common Side Effects in Programmed Death Receptor-1-directed Antibody Interactions [MoA] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Malignant neoplasm progression | 19,834 | 10,428 |
| Death | 19,612 | 19,600 |
| Off label use | 11,400 | 2,803 |
| Diarrhoea | 10,680 | 1,529 |
| Fatigue | 8,924 | 1,079 |
| Pyrexia | 8,462 | 1,244 |
| Rash | 6,811 | 693 |
| Nausea | 6,693 | 953 |
| Decreased appetite | 6,220 | 1,073 |
| Dyspnoea | 5,491 | 1,305 |